17-50175393-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: The NM_000023.4: c.1120C>T variant in SGCA is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 374, p.(Arg374Cys). The filtering allele frequency of this variant for gnomAD v4.1.0 exomes is 0.01775 (the lower threshold of the 95% CI of 63/33478 African/African American chromosomes), which is higher than the ClinGen LGMD VCEP threshold (>0.002) for BA1, and therefore meets this criterion (BA1). This variant is not located in a splice region, and the SpliceAI score is 0, which suggests it does not impact splicing. The computational predictor REVEL gives a score of 0.39, which is above the LGMD VCEP threshold predicting a benign impact on SGCA function (≤0.1; BP4 not met). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 06/24/2025): BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA180427/MONDO:0015152/189
Frequency
Consequence
NM_000023.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2DInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SGCA | NM_000023.4 | c.1120C>T | p.Arg374Cys | missense_variant | Exon 9 of 10 | ENST00000262018.8 | NP_000014.1 | |
| SGCA | NM_001135697.3 | c.748C>T | p.Arg250Cys | missense_variant | Exon 7 of 8 | NP_001129169.1 | ||
| SGCA | NR_135553.2 | n.947C>T | non_coding_transcript_exon_variant | Exon 8 of 9 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SGCA | ENST00000262018.8 | c.1120C>T | p.Arg374Cys | missense_variant | Exon 9 of 10 | 1 | NM_000023.4 | ENSP00000262018.3 |
Frequencies
GnomAD3 genomes AF: 0.00522 AC: 795AN: 152274Hom.: 5 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00171 AC: 424AN: 248192 AF XY: 0.00131 show subpopulations
GnomAD4 exome AF: 0.000658 AC: 961AN: 1460732Hom.: 4 Cov.: 31 AF XY: 0.000590 AC XY: 429AN XY: 726698 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00523 AC: 797AN: 152392Hom.: 5 Cov.: 33 AF XY: 0.00503 AC XY: 375AN XY: 74516 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2D Benign:4
- -
- -
- -
- -
not specified Benign:2
- -
- -
Autosomal recessive limb-girdle muscular dystrophy Benign:1
The NM_000023.4: c.1120C>T variant in SGCA is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 374, p.(Arg374Cys). The filtering allele frequency of this variant for gnomAD v4.1.0 exomes is 0.01775 (the lower threshold of the 95% CI of 63/33478 African/African American chromosomes), which is higher than the ClinGen LGMD VCEP threshold (>0.002) for BA1, and therefore meets this criterion (BA1). This variant is not located in a splice region, and the SpliceAI score is 0, which suggests it does not impact splicing. The computational predictor REVEL gives a score of 0.39, which is above the LGMD VCEP threshold predicting a benign impact on SGCA function (≤0.1; BP4 not met). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 06/24/2025): BA1. -
Cardiomyopathy Benign:1
- -
not provided Benign:1
- -
Sarcoglycanopathy Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at